Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 18/20 | 0.51 |
| ▸ | FAP | Q12884 | 10/20 | 0.51 |
| ▸ | POU2F2 | P09086 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | POU2F1 | P14859 | 1/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.50 |
| ▸ | HRH2 | P25021 | 1/20 | 0.50 |
| ▸ | MC4R | P32245 | 1/20 | 0.50 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.50 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.50 |
| ▸ | GHSR | Q92847 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL196304 | 0.92 | DPP4 (0.61) | DPP4FAPPOU2F2ADORA3CHRM1 | |
| SCHEMBL196303 | 0.92 | DPP4 (0.61) | DPP4FAPPOU2F2ADORA3CHRM1 | |
| SCHEMBL4474769 | 0.92 | DPP4 (0.61) | DPP4FAPPOU2F2ADORA3CHRM1 | |
| SCHEMBL29801431 | 0.92 | DPP4 (0.61) | DPP4FAPPOU2F2ADORA3CHRM1 | |
| SCHEMBL8271567 | 0.89 | DPP4 (0.53) | DPP4FAPPOU2F2ADORA3CHRM1 | |
| SCHEMBL8273231 | 0.87 | DPP4 (0.45) | DPP4FAPPOU2F2ADORA3CHRM1 | |
| SCHEMBL8272022 | 0.86 | DPP4 (0.60) | DPP4FAPPOU2F2ADORA3CHRM1 | |
| SCHEMBL8271566 | 0.86 | DPP4 (0.52) | DPP4FAPPOU2F2ADORA3CHRM1 | |
| SCHEMBL8273239 | 0.86 | DPP4 (0.43) | DPP4FAPPOU2F2ADORA3CHRM1 | |
| SCHEMBL8271560 | 0.85 | DPP4 (0.45) | DPP4FAPPOU2F2ADORA3CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1797093-B1 | NOVEL 3-METHYL-7-BUTINYL-XANTHINES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM INT (DE) | 2012-05-30 | — | — | EP | disclosed |
| US-7495002-B2 | 3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-02-24 | — | — | US | disclosed |
| US-7495002-B2 | 3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-02-24 | — | — | US | disclosed |
| WO-2006029769-A1 | NOVEL 3-METHYL-7-BUTINYL-XANTHINES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-03-23 | — | — | WO | disclosed |